Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

NCT00942864 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Retinal Vein Occlusion

Interventions

DRUG: ranibizumab

Sponsor

Novartis Korea Ltd.